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Abstract
Treatment with 0.2 mM hydrogen peroxide (H2O2) or with
0.5 mM cisplatin caused caspase-9 and caspase-3 activation
and death by apoptosis in U-937 human promonocytic cells.
However, treatment with 2 mM H2O2, or incubation with the
glutathione suppressor DL-buthionine-(S,R)-sulfoximine
(BSO) prior to treatment with cisplatin, suppressed caspase
activation and changed the mode of death to necrosis.
Treatment with 2 mM H2O2 caused a great decrease in the
intracellular ATP level, which was partially prevented by 3-
aminobenzamide (3-ABA). Correspondingly, 3-ABA restored
the activation of caspases and the execution of apoptosis. By
contrast, BSO plus cisplatin did not decrease the ATP levels,
and the generation of necrosis by this treatment was not
affected by 3-ABA. On the other hand, while all apoptosis-
inducing treatments and treatment with 2 mM H2O2 caused
Bax translocation from the cytosol to mitochondria as well as
cytochrome c release from mitochondria to the cytosol,
treatment with BSO plus cisplatin did not. Treatment with
cisplatin alone caused Bid cleavage, while BSO plus cisplatin
as well as 0.2 and 2 mM H2O2 did not. Bcl-2 overexpression
reduced the generation of necrosis by H2O2, but not by BSO
plus cisplatin. These results indicate the existence of different
apoptosis/necrosis regulatory mechanisms in promonocytic
cells subjected to different forms of oxidative stress.
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Introduction
Apoptosis and necrosis were originally described as the two
alternative forms of cell death, with well-defined morphologi-
cal and biochemical differences. Apoptosis, often considered
as equivalent to ‘programmed cell death’ (PCD), was
described as the regulated, ‘physiological’ type of death by
which the organism eliminates senescent, abnormal and
potentially harmful cells. By contrast, necrosis was described
as a passive, nonphysiological type of death caused by
cytotoxic insults.1 However, this general picture became less
clear later because (i) there are forms of PCD with
intermediate characteristics between genuine apoptosis and
necrosis2,3 and (ii) also because cytotoxic agents (such as
antitumour drugs, radiation, oxidants and hyperthermia) may
provoke cell death with characteristics of apoptosis.4–6 In
these cases, the mode of death may be often experimentally
selected by modifying the conditions of treatment.5,7,8 In
practical terms, apoptosis (or other forms of apoptosis-like
PCD)3 is clearly advantageous for the organism since it leads
to the elimination of the dying cells by phagocytosis, thus
preventing the release of intracellular content and the damage
of the surrounding tissue. Hence, it seems very important to
elucidate the mechanisms that ultimately decide the adoption
of one or the other mode of death.
A factor that may trigger cell death, and that may decide the
selection between apoptosis and necrosis, is the increase in
intracellular oxidation. Using treatment with exogenous
hydrogen peroxide (H2O2) as an experimental paradigm of
oxidation, it was often observed that moderate H2O2
concentrations triggered apoptosis, while elevated concen-
trations caused necrosis (the exact concentrations depending
very much on the used cell model).5,9–11 Moreover, the
application of a low concentration of exogenous H2O2 sufficed
to suppress apoptosis and cause necrosis-like death in
Burkitt’s lymphoma cells treated with antitumour drugs.11 In
this model, the change in the mode of death was attributed to
the oxidant-mediated depletion of intracellular ATP, which is a
strict requirement for the execution of apoptosis. However,
excessive oxidation might also suppress apoptosis by other
mechanisms, such as direct inactivation of caspases.10,12 An
alternative method to cause oxidation is by decreasing the
intracellular concentration of antioxidant molecules, making
the cell unable to cope with the normal production of reactive
oxygen species (ROS). In this manner, the depletion of
intracellular reduced glutathione (GSH) by prolonged incuba-
tion with DL-buthionine-(S,R)-sulfoximine (BSO), a specific
inhibitor of g-glutamylcysteine synthetase, caused an in-
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crease in the intracellular content of H2O2, and potentiated the
increase provoked by other treatments.13,14 Correspondingly,
the incubation with BSO potentiated the lethality of cytotoxic
treatments,13–15 leading in some cases, to a change of the
mode of death from apoptosis to necrosis.7,16
We have recently reported that the alkylating drug cis-
platinum(II)-diammine dichloride (cisplatin, CDDP), which
normally caused death by apoptosis, provoked necrosis when
applied to U-937 promonocytic cells with a reduced GSH
content.8 Although necrosis induction was accompanied by
an increased intracellular concentration of peroxides, and
could be prevented by antioxidants, it remained unclear
whether the change in the mode of death could be adequately
explained as the simple consequence of increased ROS
accumulation. As a further investigation, in the present work
we comparatively analyse some mechanisms critical for the
regulation of cell death in U-937 cells subjected to the above-
described models of oxidation, namely treatment with
exogenous H2O2, and treatment with cisplatin with and
without GSH suppression. The results demonstrate that,
among other differences, the switch from apoptosis to
necrosis in H2O2-treated cells is the consequence of ATP
depletion, while in BSO plus cisplatin-treated cells it is
independent of ATP, and apparently associated with the
inhibition of mitochondrial cytochrome c release.
Results
Death induction and caspase activities
Figure 1 compares the generation of apoptosis and necrosis
in U-937 cells treated with different concentrations of H2O2,
and with cisplatin with and without preincubation with BSO.
For quantification, the rate of apoptosis was determined by the
frequency of cells with condensed/fragmented chromatin
(Figure 1a) and with sub-G1 (hypodiploid) DNA content
Figure 1 Generation of apoptosis and necrosis by H2O2 and cisplatin. (a) Frequency of apoptotic and necrotic cells, as determined by chromatin fragmentation and
trypan blue permeability, respectively, in untreated cultures (Cont), in cultures treated for the indicated time periods with the indicated concentrations of H2O2 and in
cultures treated for the indicated time periods with 0.5 mM cisplatin (CDDP), either in the absence () or the presence of BSO. BSO (1 mM) was applied 24 h before
treatment with cisplatin. (b) Cell distribution according to PI incorporation into cultures subjected to the indicated treatments, as revealed by flow cytometry. An aliquot of
each culture was subjected to permeabilisation (left row in each group), to show the cell cycle distribution and the fraction of apoptotic (sub-G1) cells (Ap), while another
aliquot was processed without prior permeabilisation (right row in each group), to determine the fraction of cells which allowed free PI uptake (necrotic). The histograms
are representative of one of three (a) or two (b) experiments, with similar results
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(Figure 1b). The rate of necrosis was determined by the
frequency of cells with free penetration of trypan blue (Figure
1a) or propidium iodide (PI) (Figure 1b), indicating plasma
membrane damage. In both models, apoptotic cells presented
surface blebbing and reduction in size, while necrotic cells
exhibited normal chromatin distribution (similar to untreated
cells) and cell swelling (results not shown). It was observed
that treatment with 0.2 mM H2O2 only caused apoptosis, while
the concentration of 2 mM preferentially caused necrosis. As
an exception, the fraction of cells characterised as necrotic in
the 0.2 mM H2O2 treatment in Figure 1b probably represents
apoptosis-derived ‘secondary’ necrosis, because of the length
of the treatment (14 h). In these experiments, the execution of
necrosis experienced a 5–6 h delay in relation to the execution
of apoptosis (see Figure 1a). In addition, it was observed that
treatment with 0.5 mM cisplatin alone caused death by
apoptosis, but the mode of death was almost totally diverted
to necrosis if the treatment was preceded by a 24 h
preincubation with 1 mM BSO. Under these conditions the
execution of apoptosis was more rapid, and the delay of
necrosis in relation to apoptosis lower (approximately 2–3 h)
than in the case of treatments with H2O2. These differences
could not be avoided, since increasing the H2O2 concentration
(from 0.2 to 0.4 mM, and from 2 to 6 mM) did not substantially
accelerate the execution of apoptosis and necrosis; and
decreasing the cisplatin concentration to 0.05 or 0.1 mM
delayed apoptosis, but in this case the combination of BSO
plus cisplatin did not produce necrosis (results not shown). A
detailed description of other effects of cisplatin and BSO, such
as peroxide accumulation, GSH depletion, and changes in
mitochondrial transmembrane potential, was already pre-
sented in a preceding work,8 and hence is omitted here.
The capacity of H2O2 and cisplatin to cause apoptosis or
necrosis, depending on the conditions of treatment, correlated
with their capacity to activate the caspase-9/caspase-3
cascade, required for the execution of the ‘intrinsic’ pathway
of apoptosis (the pathway commonly activated by cytotoxic
treatments).17 Thus, extracts from cells treated with 0.2 mM
H2O2 or cisplatin alone exhibited a marked increase in
LEHDase (indicative of caspase-9) and DEVDase (indicative
of caspase-3) activities, while these activities were much
lower in extracts from cells treated with 2 mM H2O2 and BSO
plus cisplatin (Figure 2). These results were corroborated by
the observation that the apoptosis-inducing treatments
elicited the typical caspase-3-mediated protein kinase c
(PKC)d cleavage to give a fragment of approximately
40 kDa,18 while the cleavage was null or very poor in the
case of the necrosis-inducing treatments (see insets in
Figure 2).
ATP levels
Apoptosis is an energy-dependent process, in such a manner
that the decrease of ATP below critical levels may impede the
execution of apoptosis and promote necrosis.19,20 For this
reason, experiments were carried out to compare the
fluctuations of ATP levels upon treatment with H2O2 and
cisplatin, both under apoptosis and necrosis-inducing condi-
tions. The treatments were carried out for a maximum of 3 h, to
prevent possible ATP leakage through the damaged plasma
membranes in necrotic cells. The results are indicated in
Figure 3. Treatments with 0.2 mM H2O2 and with cisplatin
alone caused a slight decrease in the ATP level, which at 3 h
reached levels of 60–75% of the control value. Treatment with
2 mM H2O2 caused a rapid and profound depletion of ATP,
which at 1 h reached levels of around 10% in relation to control
cells. By contrast, BSO plus cisplatin did not decrease, and
even augmented the ATP content.
To corroborate the different roles of ATP for the regulation
of apoptosis/necrosis induction in the two assayed models,
Figure 2 Stimulation of caspase activities. Total cellular extracts (10 mg protein per sample) obtained from untreated cells and from cells subjected to the indicated
treatments were used to determine the caspase-9 and caspase-3 activities, using as substrates LEHD-pNA and DEVD-pNA, respectively. The results (mean7S.D. of
three determinations) are represented in relation to untreated cells, which was given the arbitrary value of one. (Insets) PKCd cleavage, as determined by
immunoblotting, at 6 h of treatment. The upper band corresponds to the whole protein (approximately 78 kDa), and the lower band to the main cleavage fragment
(approximately 40 kDa). All other conditions were as in Figure 1
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we examined the effects of the poly (ADP-ribose) polymerase
(PARP) inhibitor 3-aminobenzamide (3-ABA). This agent was
reported to preserve the ATP pool in cells treated with DNA-
damaging agents, preventing the generation of necrosis
derived from severe ATP depletion.21,22 In agreement with
this, we found that 3-ABA partially restored the ATP content in
cells treated with 2 mM H2O2, which in this case maintained a
level of at least 40% in relation to control cells (Figure 3). The
elevation of ATP levels was accompanied by the suppression
of necrosis and the restoration of apoptosis as the mode of
death (Figure 4a), and correspondingly by the restoration of
the capacity to stimulate caspase-9 and caspase-3 activities
(Figure 4b). By contrast, 3-ABA did not switch back the mode
of death from necrosis to apoptosis nor restore caspase
activities in BSO plus cisplatin-treated cells (Figure 4), which
as indicated above failed to decrease the intracellular ATP
content.
Cytochrome c release
The release of the cytochrome c from the mitochondria to the
cytosol is required for the assembly of the apoptosome and
hence for the activation of the caspase cascade in the intrinsic
pathway of apoptosis.17 However, cytochrome c release is not
necessarily a distinctive feature of apoptosis, since it was also
occasionally observed in association with necrosis.23–26 For
these reasons, immunoblot assays were carried out to detect
the presence of cytochrome c in cytosolic extracts from cells
treated with H2O2 and cisplatin, under both apoptosis- and
necrosis-inducing conditions. As indicated in Figure 5a,
cytochrome c could be detected in extracts from cells treated
with both 0.2 and 2 mM H2O2, which caused apoptosis and
necrosis, respectively. By contrast, cytochrome c was only
detected in extracts from cells treated with cisplatin alone,
which caused apoptosis, but not in extracts from cells treated
with BSO plus cisplatin, which caused necrosis. The results
obtained with cisplatin were confirmed by examining the
subcellular distribution of cytochrome c and the mitochondrial
bc1 complex, by means of immunofluorescence microscopy.
Thus, untreated cells and cells treated with BSO plus cisplatin
(necrotic) mostly exhibited yellow fluorescence, resulting from
the overlapping of the green (indicative of bc1) and red
(indicative of cytochrome c) signals. By contrast, cells treated
with cisplatin alone (apoptotic) clearly exhibited segregated
areas of red fluorescence, indicating the presence of
cytochrome c outside the mitochondria (Figure 5b).
Expression of Bcl-2 protein family members
The release of cytochrome c is regulated by proteins of the
Bcl-2 family, which may either inhibit (e.g. the antiapoptotic
proteins Bcl-2 and Bcl-XL) or promote (e.g. the proapoptotic
protein Bax) the process.27 Bax is normally present as an
inactive monomer in the cytosol, and to be functional requires
oligomerisation and translocation to the mitochondrial mem-
brane.27 In addition, cisplatin and other cytotoxic drugs may
stimulate Bid cleavage and insertion into the mitochondrial
membrane, where it also promotes cytochrome c release.28,29
For these reasons, immunoblot assays were carried out to
measure the level, integrity and subcellular distribution of Bcl-
2, Bcl-XL, Bax and Bid. The results, indicated in Figure 6, were
as follows: (i) Bcl-2, Bcl-XL and Bax were constitutively
expressed in untreated cells, and their total levels were little
affected by treatment with H2O2 and cisplatin, both under
apoptosis- and necrosis-inducing conditions (Figure 6a). (ii) In
untreated cells, Bax was mostly detected in the cytosolic
fraction and only a minimal part in the mitochondrial fraction.
Treatment with 0.2 and 2 mM H2O2 and with cisplatin alone,
which as indicated above provoked cytochrome c release,
caused a progressive increase (from 2 to 3 h) in Bax levels in
mitochondrial extracts. By contrast, there was no increase in
mitochondrial extracts from cells treated with BSO plus
cisplatin, which failed to cause cytochrome c release (Figure
6b). Bcl-2 was always undetectable in cytosolic fractions
(result not shown), and its level in the mitochondrial fractions
was not significantly modified by the treatments, being used
as an internal control (Figure 6b). (iii) Treatment with cisplatin
alone caused a progressive loss (from 2 to 3 h) of Bid proform
(21 kDa), while treatments with BSO plus cisplatin and with
0.2 and 2 mM H2O2 did not (Figure 6c). In spite of the
commercial specifications of the used antibodies, it was
almost impossible to detect Bid fragments by Western blot.
Figure 3 Modulation of ATP levels. The upper histogram shows the relative
ATP content in extracts from untreated cells (Cont), from cells treated for 3 h with
3-ABA alone, and from cells treated for the indicated time periods with 0.2 and
2 mM H2O2, with and without 3-ABA. The lower histogram shows the relative ATP
content in extracts from cells treated with BSO alone, and from cells treated for
the indicated time periods with cisplatin, with and without BSO. 3-ABA (2.5 mM)
was added 30 min before H2O2. To control the accuracy of the technique, in some
experiments the cells were incubated for 3 h in glucose-free medium
supplemented with 10 mM oligomycin (O+G), to suppress all sources of ATP
production. The results are the mean7S.D. of at least three determinations. The
ATP content in untreated cells was (24.273.1 nmol/106 cells). All other
conditions were as in Figure 1
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Hence, we consider the loss of Bid proform as an indication of
cleavage, a criterion also used by other authors.30,31
In addition to the well-known action of Bcl-2 as an
antiapoptotic factor, some reports indicate that Bcl-2 over-
expression may also inhibit necrosis.32–34 For this reason,
experiments using Bcl-2-transfected U-937 cells were carried
out to determine the effect of Bcl-2 overexpression on the
generation of necrosis by 2 mM H2O2 and BSO plus cisplatin.
Our control experiments revealed an approximately eight-fold
increase in Bcl-2 content in transfected versus nontransfected
cells (result not shown). The results are indicated in Figure 7.
It was observed that Bcl-2 overexpression decreased the
frequency of necrosis following H2O2 treatment. Of note, this
represented an effective cell protection, since the lower
frequency of necrosis was not compensated by an increase
in the frequency of apoptosis. By contrast, Bcl-2 overexpres-
sion did not protect, and even slightly accelerated the
generation of necrosis by BSO plus cisplatin. As expected,
Bcl-2 overexpression greatly inhibited apoptosis induction by
treatment with 0.2 mM H2O2 and cisplatin alone (result not
shown).
Discussion
The results in this work corroborate earlier observations
indicating that H2O2 causes apoptosis or necrosis, depending
on the concentration used,5,9,10 and that the depletion of
intracellular GSH diverts the mode of death from apoptosis to
necrosis in cells treated with cisplatin and other alkylating
agents.8,16 Since one of the main functions of GSH is to act as
a ROS scavenger, GSH depletion may cause per se an
overaccumulation of H2O2 and/or potentiate its accumulation
by treatment with cytotoxic agents, as we had in fact
demonstrated to occur in the case of cisplatin.8 Hence, one
could hypothesise that the mechanism(s) that regulate cell
death upon treatment with BSO plus cisplatin are the
same one(s) operating upon treatment with high H2O2
Figure 4 Modulation of cell death and caspase activities by 3-ABA. (a) The histograms show the frequency of apoptotic and necrotic cells, as determined by chromatin
fragmentation and trypan blue permeability, respectively, in untreated cultures (Cont) and in cultures treated for the indicated time periods with 2 mM H2O2 or with BSO
plus cisplatin, either in the absence () or the presence (+) of 3-ABA. (b) The histograms show the caspase-9 and caspase-3 activities in untreated cells (Cont), in cells
treated for 6 h with 3-ABA alone; and in cells treated for the indicated time periods with 2 mM H2O2 or with BSO plus cisplatin, with or without 3-ABA. All other conditions
were as in Figures 1–3
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concentrations. Actually, both treatments were unable to
activate the caspase-9/3 cascade, characteristic of the
mitochondrial pathway of apoptosis. However, the mechan-
isms responsible for caspase inhibition, and hence for the
suppression of apoptosis, are not coincident. Thus, while
2 mM H2O2 greatly decreased the intracellular ATP content,
but allowed cytochrome c release to the cytosol, BSO plus
cisplatin suppressed cytochrome c release, but did not
decrease ATP.
The inability of 2 mM H2O2 to cause apoptosis may be
explained by the sharp reduction in ATP levels, which
impedes the assembly of the apoptosome and hence caspase
activation.17 In addition, the lack of ATP could directly cause
necrosis by preventing the functioning of a plasma mem-
brane-associated Na+/K+ ATPase normally active during
apoptosis, with the consequence of ionic unbalance, water
uptake, and cell swelling and lysis.35 The minimum content of
intracellular ATP compatible with the execution of apoptosis
has been estimated in approximately 25% of the normal
value.20 Our results fit with this estimation, since (i) 0.2 mM
H2O2 only caused a slight (approximately 25%) reduction in
ATP levels and generated apoptosis; (ii) 2 mM H2O2 reduced
the ATP level by approximately 90% and caused necrosis and
(iii) 3-ABA restored the ATP level to approximately 40–50% of
control values and restored apoptosis. These latter results
could be explained by changes in the activity of PARP, a
molecule recently characterised as a critical switch between
apoptosis and necrosis.36 Thus, the oxidative stress caused
by elevated H2O2 concentrations may generate extensive
Figure 6 Expression and processing of Bcl-2 protein family members. Extracts
obtained from untreated cells (Cont), from cells incubated with BSO alone (BSO),
from cells treated for the indicated time periods with the indicated concentrations
of H2O2 and from cells treated for the indicated time periods with cisplatin, alone
or with BSO, were used for immunoblot assays. (a) Relative levels Bcl-2, Bax and
Bcl-XL in total cellular extracts. (b) Relative levels of Bcl-2 and Bax in
mitochondrial extracts. The numbers at the bottom of each lane represent the
corresponding Bax/Bcl-2 ratio, as determined by densitometry, in relation to the
control value. (c) Relative levels of Bid in total cellular extracts. Samples
corresponding to 15, 15 and 30 mg protein per lane were used in A, B and C,
respectively. The determinations were repeated twice in (a) and at least three
times in (b and c), with similar results. All other conditions were as in Figure 1
Figure 5 Cytochrome c release. (a) Cytosolic extracts (25 mg protein per lane)
obtained from untreated cells (Cont), from cells incubated with BSO alone (BSO),
from cells treated for the indicated time periods with the indicated concentrations
of H2O2 and from cells treated for the indicated time periods with cisplatin, with or
with BSO, were used to measure the relative level of cytochrome c by means of
immunoblotting. The level of a-tubulin was also measured as a control. The blots
are representative of one of four experiments with similar results. (b) Untreated
cells (Cont), and cells treated for 3 h with cisplatin, with or without BSO, were
fixed and processed for immunolocalisation of cytochrome c and mitochondrial
bc1 complex. The yellow fluorescence indicates colocalisation of bc1 (green
signal) and cytochrome c (red signal), while the red fluorescence in CDDP
indicates segregation of cytochrome c. The graphs indicate the distribution of
fluorescence in sections of the cells (the orientation given by a and b). All other
conditions were as in Figure 1
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DNA damage, leading to PARP activation, NAD+ consumption
and massive ATP depletion.37 Under these conditions, the
administration of 3-ABA may inhibit PARP activation, partially
preserving the ATP pool. Alternatively or complementarily,
H2O2 might suppress the de novo ATP synthesis by inhibiting
mitochondrial respiration and/or glycolytic enzyme activ-
ities;38 and 3-ABA could preserve ATP by preventing the
block of glycolysis.39 Whatever the case, it seems clear that
the generation of necrosis by BSO plus cisplatin is indepen-
dent of ATP, as far as the treatment did not reduce the ATP
level, and necrosis was not prevented by 3-ABA.
Another manner in which H2O2 could suppress apoptosis is
by direct inactivation of caspases, because of the oxidation of
the cysteine residues in their catalytic sites10 (although this
mechanism has been challenged).40 This was apparently the
case in menadione-treated HepG2 cells, where menadione
increased oxidation, decreased ATP levels and caused
necrosis, but necrosis could not be prevented by the elevation
of ATP.12 However, this mechanism does not seem to operate
in our model, since the increase of ATP levels by 3-ABA
sufficed to restore caspase activities and apoptosis. Of note,
we and others have reported that the administration of the pan-
caspase inhibitor Z-VAD-Fmk prevented the execution of
apoptosis in U-937 cells.8,41,42 However, in this case the
suppression of apoptosis was not accompanied by cell
swelling, and plasma membrane integrity was only affected at
approximately 24 h (i.e. much later than in our present
experiments). This may be in agreement with reports indicating
that caspase inhibition per se might be insufficient to cause
classical necrosis.3 Hence, the generation of necrosis under
oxidant conditions (treatment with H2O2 or GSH depletion)
probably involves additional physiological disturbances, for
example, ionic unbalance, as indicated above.
The inability of BSO plus cisplatin to activate the caspase
cascade and hence to cause apoptosis may be adequately
explained by the lack of cytochrome c release from
mitochondria to the cytosol; and the lack of cytochrome c
release could be the consequence, at least in part, of the lack
of Bax translocation to mitochondria. Actually, there was
always a correlation between Bax translocation and cyto-
chrome c release in the two types of treatments used, H2O2
and cisplatin. In addition, Bid might participate in the
regulation of cytochrome c release in cisplatin-treated cells,
since cisplatin alone caused Bid cleavage (as deduced from
the disappearance of the 21 kDa proform), while BSO plus
cisplatin did not. Noteworthy, H2O2 failed to stimulate Bid
processing under all used conditions, a result also reported by
other authors.31 The disparity in the behaviour of Bid might
indicate that, in addition to necrosis, apoptosis is also
differentially regulated in cells subjected to H2O2 and cisplatin.
Finally, although no attempts were made to examine the
influence of Bcl-2 expression on cytochrome c release, the
experiments using Bcl-2-transfected cells lead to interesting
results. On the one hand, Bcl-2 overexpression reduced the
generation of both apoptosis and necrosis by H2O2. This was
not surprising, since one of the earlier described actions of
Bcl-2 is to activate antioxidant functions in the cell,43,44 and
other reports also indicated inhibition by Bcl-2 of necrosis
induction by H2O2 and other cytotoxic treatments.
32–34 By
contrast, Bcl-2 overexpression did not reduce, and even
facilitated the generation of necrosis by BSO plus cisplatin.
This result was unexpected, since Bcl-2 was reported to
counteract the increase in toxicity generated by GSH
depletion.44,45 A full understanding of these results requires
a deeper investigation, but meanwhile they reinforce the
conclusion of a different regulation of necrosis induction by
H2O2 and BSO plus cisplatin.
Although one of the roles of GSH is the scavenging of
peroxides, GSH also regulates other important aspects of the
redox equilibrium. For instance, glutathione may form
reversible mixed disulphides with protein thiols, preventing
irreversible oxidation of cysteine residues under oxidative
stress.46 Hence, the lack of GSH upon prolonged treatment
with BSO could compromise this defensive function. In
addition, the lack of GSH may result in an increase in the
intracellular free, acting concentration of alkylating drugs,
since these drugs are detoxified by GSH conjugation.47 This is
also important, since cisplatin is a very reactive molecule,
which directly binds nucleophilic sites of many cellular
components, including proteins.48 In these ways, BSO plus
Figure 7 Effect of Bcl-2 overexpression on the generation necrosis.
(a) Frequency of apoptotic and necrotic cells, as determined by chromatin
fragmentation and trypan blue permeability, respectively, in nontransfected (U-
937) and Bcl-2-transfected (U-937-Bcl-2) cell cultures treated for the indicated
time periods with the 2 mM H2O2 or with BSO plus cisplatin. (b) Frequency of
necrotic cells using the same cell types and treatments, as revealed by PI
penetration and flow cytometry. The values were repeated three times (a) and
twice (b) with similar results. All other conditions were as in Figure 1
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cisplatin could severely alter the function of proteins critical for
apoptosis–necrosis regulation – such as Bcl-2 family mem-
bers (as demonstrated here in the case of Bax) and/or
mitochondrial permeability transition pore constituents.49 This
might explain the existence of substantial differences in the
regulation of cell death by different forms of oxidative stress –
namely, direct treatment with H2O2 versus GSH depletion.
Materials and Methods
Chemicals
All components for cell culture were obtained from Life Technologies, Inc.
(Gaithersburg, MD, USA). 4,6-diamidino-2-phenylindole was obtained
from Serva (Heidelberg, Germany); RNase A from Roche Diagnostics,
S.L. (Barcelona, Spain); digitonin, caspase-3 substrate I, (Ac-DEVD-pNA)
and caspase-9 substrate II (LEHD-pNA) from Calbiochem (Darmstadt,
Germany); and 3-ABA, BSO, DL-dithiothreitol, cisplatin, oligomycin, PI and
protease inhibitor cocktail from Sigma (Madrid, Spain). Mouse anti-human
Bcl-2 (100) monoclonal antibody (mAb), rabbit anti-human Bax (N-20)
polyclonal antibody (pAb), and rabbit anti-human nPKCd (C-20) pAb were
from Santa Cruz Biotechnology, Inc. (Santa Cruz, CA, USA). Rabbit anti-
human Bcl-XL pAb was from Transduction Laboratories (Lexington, KY,
USA). Mouse anti-pigeon cytochrome c mAb (clone 7H8.2C12, used for
immunoblot assays) and mouse anti-rat cytochrome c mAb (clone 6H2.B4,
used for immunofluorescence microscopy) were from BD PharMingen
(San Diego, CA, USA). Goat anti-human Bid (C-20) and goat anti-mouse
Bid pAbs were obtained from Santa Cruz Biotechnology and R&D
Systems, Inc. (Wiesbaden-Nordenstad, Germany). Mouse anti-human
COX II was obtained from Molecular Probes (Eugene, OR, USA). Rabbit
anti-rat bc1 complex was a generous gift of Professor R Bisson, Padova,
Italy. Mouse anti-chicken a-tubulin mAb, fluorescein isothiocyanate-
conjugated goat anti-rabbit IgG, and tetramethylrhodamine isothiocya-
nate-conjugated goat anti-mouse IgG were from Sigma. Peroxidase-
conjugated rabbit anti-mouse IgG and peroxidase-conjugated goat anti-
rabbit IgG were from DAKO Diagno´sticos, S.A. (Barcelona, Spain).
Cell culture and treatments
U-937 human promonocytic leukemia cells,50 and Bcl-2-transfected U-937
cells (kindly provided by Dr. Jacqueline Bre´ard, INSERM 461, Chatenay
Malabry, France) were grown in RPMI 1640 supplemented with 10% (v/v)
heat-inactivated fetal calf serum (FCS), and 0.2% sodium bicarbonate and
antibiotics in a humidified 5% CO2 atmosphere at 371C. 4,6-diamidino-2-
phenylindole (10 mg/ml) and PI (1 mg/ml) were dissolved in phosphate-
buffered saline (PBS), and cisplatin (3.3 mM) in distilled water. These
solutions were stored at 41C. 3-ABA (100 mM) was dissolved in distilled
water and stored at201C. BSO (50 mM) was freshly prepared in distilled
water, just before use. Typically, the cells were seeded at 2 105 cells/ml
24 h before treatment with cisplatin or H2O2. For GSH depletion, the cells
were incubated for 24 h with 1 mM BSO, before treatment with cisplatin.
Under these conditions BSO caused an approximately 70% reduction in
total GSH content, but did not affect cell proliferation or viability. To obtain
a complete ATP depletion, the cells were incubated in the presence of
10mM oligomycin in glucose-free RPMI medium, supplemented with 1 mM
sodium pyruvate and 10% (v/v) dialysed FCS.
Determination of apoptosis and necrosis
To analyse changes in nuclear morphology, the cells were collected by
centrifugation, washed with PBS, resuspended in PBS and mounted on
glass slides. After fixation in 70% (v/v) ethanol, the cells were stained for
20 min at room temperature in PBS containing 1 mg/ml 4,6-diamidino-2-
phenylindole and examined by fluorescence microscopy. Apoptosis was
characterised by chromatin condensation followed by partition into multiple
bodies. Within the experimental time periods used in this work,
nonapoptotic, primary necrotic cells still exhibited diffuse and uniform
chromatin staining, as untreated cells. To measure loss of DNA, cells were
collected by centrifugation and incubated for 30 min in PBS containing
0.5 mg/ml RNase A and 0.1% (w/v) Nonidet P-40. After the addition of PI
(final concentration of 50 mg/ml), the cells were analysed by flow
cytometry. Late apoptotic cells exhibited sub-G1 PI incorporation
(hypodiploid cells). Within the experimental time periods used in this
work, nonapoptotic, primary necrotic cells did not exhibit significant loss of
DNA, nor significant alterations in the cell cycle distribution in relation to
untreated cells.
The criterion currently used to examine necrosis was the loss of
membrane integrity, as measured by massive influx of either trypan blue or
PI in nonpermeabilised cells. In the first case, cells were incubated for
5 min with 0.2% (w/v) trypan blue and examined by microscopy using a
Neubauer haemacytometer. Under these conditions, only necrotic cells
were clearly stained. In the second case, nonpermeabilised cells were
suspended in PBS containing 50mg/ml PI, and the fluorescence was
analysed by flow cytometry. Under these conditions only necrotic cells
exhibited great fluorescence, while the fluorescence was null or very low in
apoptotic cells.
Caspase activity assays
Samples of 4 106 cells were collected by centrifugation, washed twice
with ice-cold PBS, resuspended in 50ml of ice-cold lysis buffer (1 mM DL-
dithiothreitol, 0.03% Nonidet P-40 (v/v), in 50 mM Tris pH 7.5), kept on ice
for 30 min and finally centrifuged at 14 000 g for 15 min at 41C. Samples
containing aliquots of the supernatants (corresponding to 10 mg of total
protein), 8 ml of the appropriate caspase substrate (Ac-DEVD-pNA for
caspase-3, and LEHD-pNA for caspase-9), and PBS to complete 200 ml,
were prepared by triplicate in 96-well microtiter plates, and incubated for
1 h at 371C. The absorption was measured by spectrometry at 405 nm.
Measurement of ATP levels
To estimate the intracellular ATP content, aliquots of 2 106 cells were
collected in a preheated (701C) buffer consisting of 100 mM Tris and 4 mM
EDTA, pH 8, and heated for 2 min at 1001C. After cooling on ice and
centrifugation at 10 000 g for 1 min at 41C, the ATP content in the
supernatants was determined using an ATP Bioluminescence Assay Kit
CLSII (Roche Diagnostics, Barcelona, Spain), following the procedure
indicated by the manufacturer, and a TD-20/29 luminometer (Turner
Designs, Sunnyvale, CA, USA). ATP standard curves (linear in the range
of 5–500 nM) were carried out in all experiments. Extracts from cells
depleted of ATP by incubation with oligomycin-containing glucose-free
medium were routinely used as control of the technique.
Protein extraction, subcellular fractionation and
immunoblot assays
To obtain total cellular protein extracts, samples of 3 106 cells were
collected by centrifugation, washed with PBS and lysed by 5 min heating at
1001C in Laemmli’s buffer containing protease inhibitors followed by
sonication. To obtain cytosolic extracts for the determination of
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cytochrome c release, samples of 3 106 cells were collected by
centrifugation, and permeabilised for 5 min in 100 ml of ice-cold PBS
containing 80 mM KCl, 250 mM sucrose and 200 mg/ml digitonin. After
centrifugation, the pellet was discarded and the supernatant used for
immunoblotting. Control determinations using anti-COX II antibody
revealed that the supernatants were free of mitochondrial contamination.
To obtain mitochondrial and cytosolic extracts for the determination of Bax
localisation, the subcellular fractionation procedure described by Kim et
al.51 was followed, with minor modifications. Samples of 107 cells were
washed with PBS and resuspended in 300 ml of solution A (20 mM
HEPES–KOH, pH.7.5, 10 mM KCl, 1.5 mM MgCl2, 1 mM EDTA, 1 mM
EGTA, 1 mM dithiothreitol, supplemented with 250 mM sucrose and
protease inhibitors). The cells were lysed by passing them five times
through a 25-gauge needle, after which the homogenates were
centrifuged for 10 min at 1000 g at 41C to remove unbroken cells, nuclei
and large membrane fragments. The upper part of the supernatant
(approximately 200 ml) was carefully removed and centrifuged for 20 min
at 10 000 g at 41C. The resulting pellet (mitochondrial fraction) was
washed with solution A, centrifuged again, and solubilised by heating and
sonication in Lammli’s buffer containing protease inhibitors. The resulting
supernatant was centrifuged for 1 h at 100 000 g at 41C to obtain the
cytosolic fraction. Control experiments using anti-COX II and anti-a-tubulin
antibodies were carried out to check the purity of mitochondrial and
cytosolic fractions. In all cases, the detection of specific proteins either in
the total cellular extracts or in the cell fractions was carried out by
immunoblot, following the previously described procedure.52
Immunofluorescence microscopy
U-937 cells immobilised on slides were processed for simultaneous
detection of cytochrome c and bc1, following the earlier described
procedure.53
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